Dudakov JA, Hanash AM, van den Brink MRM. Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015;33:747–85. https://doi.org/10.1146/annurev-immunol-032414-112123.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shuttleworth S, Townsend P, Silva F, et al. Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases. Prog Med Chem. 2011;50:109–33. https://doi.org/10.1016/b978-0-12-381290-2.00003-3.

Article  CAS  PubMed  Google Scholar 

Sonnenberg GF, Fouser LA, Artis D. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv Immunol Mucosal Immun. 2010. https://doi.org/10.1016/b978-0-12-381300-8.00001-0.

Article  Google Scholar 

Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29(1):71–109. https://doi.org/10.1146/annurev-immunol-031210-101312.

Article  CAS  PubMed  Google Scholar 

Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld J-C. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. J Biol Chem. 2002;277(37):33676–82. https://doi.org/10.1074/jbc.m204204200.

Article  CAS  PubMed  Google Scholar 

Arellano ACARCADD, Lopez-Pulido EI, Martínez-Neri PA, et al. STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells. Cancer Cell Int. 2015. https://doi.org/10.1186/s12935-015-0234-9.

Article  PubMed Central  Google Scholar 

Demaria M, Poli V. Pro-malignant properties of STAT3 during chronic inflammation. Oncotarget. 2012;3(4):359–60.

Article  PubMed  PubMed Central  Google Scholar 

Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2010;278(1):16–27. https://doi.org/10.1111/j.1742-4658.2010.07919.x.

Article  CAS  PubMed  Google Scholar 

Mühl H, Scheiermann P, Bachmann M, Härdle L, Heinrichs A, Pfeilschifter J. IL-22 in tissue-protective therapy. Br J Pharmacol. 2013;169(4):761–71. https://doi.org/10.1111/bph.12196.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez DV, Kongsbak-Wismann M. Role of IL-22 in homeostasis and diseases of the skin. APMIS. 2022;130(6):314–22. https://doi.org/10.1111/apm.13221.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arshad T, Mansur F, Palek R, Manzoor S, Liska V. A double edged sword role of interleukin-22 in wound healing and tissue regeneration. Front Immunol. 2020;11:2148. https://doi.org/10.3389/fimmu.2020.02148.PMID:33042126;PMCID:PMC7527413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perusina Lanfranca M, Lin Y, Fang J, Zou W, Frankel T. Biological and pathological activities of interleukin-22. J Mol Med (Berl). 2016;94(5):523–34. https://doi.org/10.1007/s00109-016-1391-6.

Article  CAS  PubMed  Google Scholar 

Wang X, Wong K, Ouyang W, Rutz S. Targeting IL-10 family cytokines for the treatment of human diseases. Cold Spring Harb Perspect Biol. 2019;11(2): a028548. https://doi.org/10.1101/cshperspect.a028548.PMID:29038121;PMCID:PMC6360861.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kirchberger S, Royston DJ, Boulard O, et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med. 2013;210(5):917–31. https://doi.org/10.1084/jem.20122308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khawar MB, Azam F, Sheikh N, Mujeeb KA. How does interleukin-22 mediate liver regeneration and prevent injury and fibrosis? J Immunol Res. 2016. https://doi.org/10.1155/2016/2148129.

Article  PubMed  PubMed Central  Google Scholar 

Xie M-H, Aggarwal S, Ho W-H, et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2–4 and IL-22R. J Biol Chem. 2000;275(40):31335–9. https://doi.org/10.1074/jbc.m005304200.

Article  CAS  PubMed  Google Scholar 

Kotenko SV. The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev. 2002;13(3):223–40. https://doi.org/10.1016/s1359-6101(02)00012-6.

Article  CAS  PubMed  Google Scholar 

Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 2000;1:488–94.

Article  CAS  PubMed  Google Scholar 

Mak TW, Saunders ME. Cytokines and cytokine receptors. The Immune Response. 2006. https://doi.org/10.1016/b978-012088451-3.50019-3.

Article  Google Scholar 

IL-22RA1 interleukin 22 receptor subunit alpha 1 [homo sapiens (human)]. PubMed.

Bleicher L. Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett. 2008;582:2985–92.

Article  CAS  PubMed  Google Scholar 

Brockmann L, Giannou AD, Gagliani N, Huber S. Regulation of TH17 cells and associated cytokines in wound healing, tissue regeneration, and carcinogenesis. Int J Mol Sci. 2017;18(5):1033. https://doi.org/10.3390/ijms18051033.PMID:28492497;PMCID:PMC5454945.

Article  PubMed  PubMed Central  Google Scholar 

Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O’Connor W Jr, Murphy AJ, Valenzuela DM, Yancopoulos GD, Booth CJ, Cho JH, Ouyang W, Abraham C, Flavell RA. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature. 2012;491(7423):259–63. https://doi.org/10.1038/nature11535.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katara GK, Kulshrestha A, Schneiderman S, Riehl V, Ibrahim S, Beaman KD. Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer. Mol Oncol. 2020;14(1):211–24. https://doi.org/10.1002/1878-0261.12598.

Article  CAS  PubMed  Google Scholar 

Yang SB, Han F, Wu JH, Zhao Z, Zhan W. Association between CXCR2 and IL-22BP expression indicate a poor outcome for gastric adenocarcinoma progression. Oncol Lett. 2016;12(2):1477–84. https://doi.org/10.3892/ol.2016.4790.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lerman G, Sharon M, Leibowitz-Amit R, Sidi Y, Avni D. The Crosstalk between IL-22 Signaling and miR-197 in Human Keratinocytes. PLoS ONE. 2014. https://doi.org/10.1371/journal.pone.0107467.

Article  PubMed  PubMed Central  Google Scholar 

Kempski J, Giannou AD, Riecken K, Zhao L, Steglich B, Lücke J, Garcia-Perez L, Karstens KF, Wöstemeier A, Nawrocki M, Pelczar P, Witkowski M, Nilsson S, Konczalla L, Shiri AM, Kempska J, Wahib R, Brockmann L, Huber P, Gnirck AC, Turner JE, Zazara DE, Arck PC, Stein A, Simon R, Daubmann A, Meiners J, Perez D, Strowig T, Koni P, Kruglov AA, Sauter G, Izbicki JR, Guse AH, Rösch T, Lohse AW, Flavell RA, Gagliani N, Huber S. IL22BP mediates the antitumor effects of lymphotoxin against colorectal tumors in mice and humans. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.06.033.

Article  PubMed  Google Scholar 

Martin JC, Bériou G, Heslan M, Chauvin C, Utriainen L, Aumeunier A, Scott CL, Mowat A, Cerovic V, Houston SA, Leboeuf M, Hubert FX, Hémont C, Merad M, Milling S, Josien R. Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol. 2014;7(1):101–13. https://doi.org/10.1038/mi.2013.28.